Otero Jose Manuel Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$13,294.46

Insider Activity of Otero Jose Manuel

According to the SEC Form 4 filings, Otero Jose Manuel, being in a position of

  1. Chief Operating Officer at Lexeo Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 11009 shares for $59,952,
    over all time since 2025-08-18, has bought 0 shares, and sold 16693 shares for $98,842.

Biography of Otero Jose Manuel

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $59,9525100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Operating Officer
1,304
0.0017%
$4.96$6,464-29.61%
2026-07-01SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Operating Officer
4,666
0.0057%
$4.48$20,904-1.35%
2026-05-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Operating Officer
1,302
0.0018%
$5.07$6,606-3.4%
2026-02-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Operating Officer
3,016
0.0042%
$6.40$19,294-23.05%
2025-11-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Operating Officer
721
0.0022%
$9.27$6,684-41.01%
2025-10-17SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Technical Officer
2,115
0.0059%
$8.94$18,913-39.77%
2025-08-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Technical Officer
2,848
0.0081%
$4.67$13,294+28.25%
2025-08-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Technical Officer
721
0.0041%
$9.27$6,684+28.25%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.